Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Microbiol ; 192(9): 775-81, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20652229

ABSTRACT

Endodontic restorations often fail due to inadequate disinfection of the root canal even though the antimicrobial irrigants used have been shown to be capable of killing the bacterium frequently implicated in this complication, Enterococcus faecalis (Ef). Extracted human teeth were root-prepared and filled with a liquid culture of Ef. Following incubation, the root canals were irrigated with 1% sodium hypochlorite (NaOCl), electrochemically activated water or saline control. Irrigation was modelled using an electronic pipette to deliver the solutions at a reproducible flow velocity. A series of parallel experiments employed a membrane biofilm model that was directly immersed into irrigant. Experimental conditions where contiguous between the extracted tooth model and biofilm model wherever possible. After 60 s of exposure, 1% NaOCl effectively sterilised the biofilm model, whereas log 3.36 viable Ef where recoverable from the analogous extracted tooth model, the other irrigants proved ineffective. Biofilms of Ef were susceptible to concentrations of irrigant that proved ineffective in the tooth model. NaOCl was the most effective biocide in either case. This suggests that the biofilm modality of bacterial growth may not be the most important factor for the recalcitrance of root canal infections during endodontic irrigation; it is more likely due to the inability of the irrigant to access the infection.


Subject(s)
Biofilms/growth & development , Dental Pulp Cavity/microbiology , Enterococcus faecalis/growth & development , Models, Biological , Tooth/microbiology , Biofilms/drug effects , Enterococcus faecalis/drug effects , Humans , Root Canal Irrigants/pharmacology , Root Canal Preparation , Sodium Hypochlorite/pharmacology
2.
Dent Traumatol ; 24(2): 189-92, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18352922

ABSTRACT

The objectives of this study were to assess the prevalence of oro-facial injuries, frequency of mouthguard use and players' attitudes towards the use of mouthguards among elite English female field hockey players. All 140 players of the English Hockey Association female Premiere League were asked to complete a questionnaire. Main outcome measures were prevalence of oro-facial injuries, frequency of wearing of mouthguards and attitudes to mouthguard wearing. One hundred and ten completed questionnaires were returned (79% response rate). Facial injuries were common. Nineteen percent had sustained dental injury. Five percent of the respondents had at least one tooth avulsed. Eighty-eight percent of the players said that they owned a mouthguard. Mouthguards were worn regularly during matches by 69% but were used less frequently during training. Six percent thought that mouthguards were ineffective. Eighteen percent of the subjects refused to play if they did not have their mouthguard. Sixty-nine percent of the subjects felt that the mouthguards should be worn compulsorily at all times during the game. The following were finally concluded from the study: oro-facial injuries were commonly reported; 88% of the players possessed a mouthguard; and mouthguards were worn regularly during matches by 69% but were used less frequently during training.


Subject(s)
Athletic Injuries/epidemiology , Hockey/injuries , Maxillofacial Injuries/epidemiology , Mouth Protectors/statistics & numerical data , Tooth Injuries/epidemiology , Adult , Athletic Injuries/prevention & control , Athletic Injuries/psychology , Attitude to Health , England/epidemiology , Female , Humans , Maxillofacial Injuries/prevention & control , Maxillofacial Injuries/psychology , Prevalence , Surveys and Questionnaires , Tooth Injuries/prevention & control , Tooth Injuries/psychology
3.
J Neurosci Res ; 74(6): 934-41, 2003 Dec 15.
Article in English | MEDLINE | ID: mdl-14648599

ABSTRACT

We investigated the action of the acridine derivative, quinacrine (QC), which has been shown to act as a noncompetitive channel inhibitor. The main effects of QC are voltage- and concentration-dependent changes in the kinetics of the prion protein fragment (PrP[106-126])-formed cation channels. The current-voltage relationships show that the maximal current (I) was not affected whereas the physiologically important mean current (I') was reduced as a result of changes in channel kinetics. These findings suggest that QC acts on the open state of the channels. The half-inhibitory concentration (IC50) for the dose-dependent effects of [QC]cis on the kinetic parameters of the PrP(106-126)-formed cation channel shows a reduction in the ratios Po(QC)/Po, Fo(QC)/Fo, and To(QC)/To, whereas Tc(QC)/Tc increases. Of these ratios, Po(QC)/Po was more sensitive than the others. The corresponding IC50 for these ratios were 51, 94, 86, and 250 microM QC, respectively. The QC-induced changes in the kinetic parameters were more apparent at positive voltages. IC50 values for Po were 95, 75, and 51 microM at +20, +80, and +140 mV, respectively. The fact that QC induced changes in the kinetics of this channel, although the conductance of the channel remained unchanged, indicates that QC may bind at the mouth of the channel via a mechanism known as fast channel block. The QC-induced changes in the kinetic parameters of this channel suggest that they are pathophysiologically significant because these channels could be the mechanisms by which amyloids induce membrane damage in vivo.


Subject(s)
Ion Channels/antagonists & inhibitors , Ion Channels/physiology , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/physiology , Prions/antagonists & inhibitors , Prions/physiology , Quinacrine/pharmacology , Dose-Response Relationship, Drug , Lipid Bilayers/antagonists & inhibitors
4.
Am J Physiol Cell Physiol ; 285(4): C862-72, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12814912

ABSTRACT

A major prion protein (PrP) mutant that forms amyloid fibrils in the diseased brain of patients with Gerstmann-Sträussler-Scheinker syndrome (GSS) is a fragment of 7 kDa spanning from residues 81-82 to 144-153 of PrP. Analysis of ionic membrane currents, recorded with a lipid bilayer technique, revealed that the wild-type fragment PrP(82-146) WT and the partially scrambled PrP(82-146) (127-146) SC are capable of forming heterogeneous ion channels that are similar to those channels formed with PrP(106-126). In contrast, PrP(82-146) peptides in which the region from residue 106 to 126 had been scrambled (SC) showed a reduction in interaction with lipid membranes and did not form channels. The PrP(82-146) WT- and PrP(82-146) (127-146) SC-formed cation channels with fast kinetics are Cu2+ sensitive and rifampicin (RIF) insensitive, whereas the time-dependent inactivating channels formed by these same peptides are both Cu2+ and RIF insensitive. The presence of RIF in the solution before the addition of PrP(82-146) WT or PrP(82-146) (127-146) SC affected their incorporation into the lipid bilayers. PrP(82-146) WT and PrP(82-146) (127-146) SC fast cation channels formed in the presence of RIF appeared in an electrically semisilent state or an inactivated state. Increasing [Cd2+]cis enhanced the incorporation of PrP(82-146) WT and PrP(82-146) (127-146) SC channels formed in the presence of RIF. We conclude that the major PrP mutant fragment in the diseased brain of GSS patients is prone to form channels in neuronal membranes, causing their dysfunction. We propose that Cd2+ may accentuate the neurotoxicity of this channel-forming PrP fragment by enhancing its incorporation into the membrane.


Subject(s)
Brain/metabolism , Gerstmann-Straussler-Scheinker Disease/metabolism , Ion Channels/metabolism , Mutation , Peptide Fragments/genetics , Peptide Fragments/metabolism , Prions/genetics , Prions/metabolism , Cadmium/pharmacology , Cations/metabolism , Drug Synergism , Electric Conductivity , Humans , Ion Channels/physiology , Lipid Bilayers , Osmolar Concentration , Peptide Fragments/chemical synthesis , Peptide Fragments/pharmacology , Prions/chemical synthesis , Prions/pharmacology , Sequence Homology , Time Factors
5.
Am J Physiol Cell Physiol ; 285(4): C873-80, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12814914

ABSTRACT

We found that the amyloid beta peptide A beta(1-42) is capable of interacting with membrane and forming heterogeneous ion channels in the absence of any added Cu2+ or biological redox agents that have been reported to mediate A beta(1-42) toxicity. The A beta(1-42)-formed cation channel was inhibited by Cu2+ in cis solution ([Cu2+]cis) in a voltage- and concentration-dependent manner between 0 and 250 microM. The [Cu2+]cis-induced channel inhibition is fully reversible at low concentrations between 50 and 100 microM [Cu2+]cis and partially reversible at 250 microM [Cu2+]cis. The inhibitory effects of [Cu2+]cis between 50 and 250 microM on the channel could not be reversed with addition of Cu2+-chelating agent clioquinol (CQ) at concentrations between 64 and 384 microM applied to the cis chamber. The effects of 200-250 microM [Cu2+]cis on the burst and intraburst kinetic parameters were not fully reversible with either wash or 128 microM [CQ]cis. The kinetic analysis of the data indicate that Cu2+-induced inhibition was mediated via both desensitization and an open channel block mechanism and that Cu2+ binds to the histidine residues located at the mouth of the channel. It is proposed that the Cu2+-binding site of the A beta(1-42)-formed channels is modulated with Cu2+ in a similar way to those of channels formed with the prion protein fragment PrP(106-126), suggesting a possible common mechanism for Cu2+ modulation of A beta and PrP channel proteins linked to neurodegenerative diseases.


Subject(s)
Amyloid beta-Peptides/metabolism , Copper/pharmacology , Ion Channels/drug effects , Ion Channels/metabolism , Peptide Fragments/metabolism , Chelating Agents/pharmacology , Clioquinol/pharmacology , Electric Conductivity , Electrophysiology , Ion Channels/antagonists & inhibitors , Ion Channels/physiology , Kinetics
6.
Cell Biochem Biophys ; 36(2-3): 191-207, 2002.
Article in English | MEDLINE | ID: mdl-12139405

ABSTRACT

The amyloidoses consist of human and animal chronic, progressive, and sometimes fatal diseases that are characterized by the deposition of insoluble proteinaceous amyloid fibrils in various tissues. Despite the biochemical diversity of amyloids, they share certain properties. The amphipathic and the charged nature of many amyloid-forming peptides point to their intrinsic ability to form diverse beta-sheet-based aggregates and channel types in negatively charged membranes. We hypothesize that the formation of heterogeneous channels represents a common cytotoxic mechanism that accentuates the changes in the signal transduction that underlie amyloid-induced cell malfunction. One group of amyloid-forming peptides that could mediate their action via the formation of heterogeneous channels includes the extensively examined prions and amyloid beta protein that are associated with conformational neurodegenerative diseases. The aim of this study is to examine heterogeneous channels formed in bilayers with amyloid-forming peptides as a common mechanism of malfunction of signal transduction. The observed amyloid-formed channel types include the following. (1) Natriuretic peptides: (i) 68-pS H2O2- and Ba2+-sensitive channel with fast kinetics. The fast channel had three modes (spike mode, burst mode, and open mode), which differ in their kinetics but not in their conductance properties; (ii) a 273-pS inactivating large conductance channel; and (iii) a 160-pS transiently activated channel. (2) Prions: (i) a 140-pS GSSG- and TEA-sensitive channel with fast kinetics; (ii) a 41-pS dithiothreitol (DTT)-sensitive channel with slow kinetics; (iii) a 900 to 1444-pS large channel. (3) Amyloid beta protein: (i) a 17 to 63-pS AbetaP[1-40]-formed "bursting" fast cation channel, (ii) the AbetaP[1-40]-formed "spiky" fast cation channel with a similar kinetics to the "bursting" fast channel except for the absence of the long intraburst closures, (iii) 275-pS AbetaP[1-40]-formed medium conductance channel, and (iv) 589- to 704-pS AbetaP[1-40]-formed inactivating large conductance channel. This heterogeneity is one of the most common features of these charged cytotoxic amyloid-formed channels, reflecting these channels' ability to modify multiple cellular functions. Although the diversity of these aggregated-peptide-formed channels may indicate that a stochastic mechanism governs their formation, the fact that certain channel types are often observed point to preferential channel protein conformations. In addition, the fact that other amyloids have similar structural properties (e.g. hydrophobicity, charged residues, and beta-structural linkages, suggests that, despite the intrinsic ability to form diverse conformations, certain conformations and, hence, certain channel types could be a common pathologic conformation among these amyloid-forming peptides. It is concluded that conformation-based channel diversity is an important mechanism for enhancing the toxicity of amyloid-forming peptides. The cytotoxic nature of these self-associated beta-based protein channels suggests that under normal physiological conditions cells employ well-evolved protective mechanisms against seeding and/or propagation of channel-forming peptides; for example, (a) compartmentalization of these peptides as membrane bound in internal vesicles and/or (b) degradation of these peptides by enzymes. The pharmacological diversity of the amyloid-forming channels implies that multiple therapeutic interventions may be necessary for blocking and reversing heterogeneous channel formations and preventing their associated diseases.


Subject(s)
Amyloid beta-Peptides/chemistry , Ion Channels/chemistry , Prions/chemistry , Amyloid/metabolism , Amyloid beta-Peptides/physiology , Amyloidosis/prevention & control , Animals , Atrial Natriuretic Factor/metabolism , Humans , Ion Channels/physiology , Ion Channels/toxicity , Islet Amyloid Polypeptide , Lipid Bilayers/metabolism , Natriuretic Peptide, C-Type/metabolism , Neurodegenerative Diseases/metabolism , Prions/physiology , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...